Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma.
about
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells.Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.
P2860
Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@ast
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@en
type
label
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@ast
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@en
prefLabel
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@ast
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@en
P2093
P2860
P1433
P1476
Trefoil factor 3 as a novel bi ...... a and squamous cell carcinoma.
@en
P2093
Peter E Lobie
Shu-Jing Wang
Vijay Pandey
Xiao-Nan Wang
Zheng-Sheng Wu
P2860
P356
10.1097/MD.0000000000000860
P407
P577
2015-05-01T00:00:00Z